Navigation Links
Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children
Date:5/13/2008

ward the development of treatments for this group of underserved inherited neurodegenerative disorders," says James M. Wilson, MD, PhD, Editor-in-Chief and Head of the Gene Therapy Program, Department of Pathology and Laboratory Medicine, at the University of Pennsylvania School of Medicine, in Philadelphia.

Human Gene Therapy, the Official Journal of the European Society of Gene and Cell Therapy and the British Society for Gene Therapy, is an authoritative peer-reviewed journal published monthly in print and online that presents reports on the transfer and expression of genes in mammals, including humans. Related topics include improvements in vector development, delivery systems, and animal models, particularly in the areas of cancer, heart disease, viral disease, genetic disease, and neurological disease, as well as ethical, legal, and regulatory issues related to the gene transfer in humans. Tables of contents and a free sample issue may be viewed online.

Mary Ann Liebert, Inc. (http://www.liebertpub.com), is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Tissue Engineering, Stem Cells and Development, and Cloning and Stem Cells. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals, books, and newsmagazines is available online.

Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext. 2156, vcohn@liebertpub.com


'/>"/>
SOURCE Mary Ann Liebert, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
2. Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals
3. New Data Show High Frequency of Medical Claims for Gastrointestinal Events by Patients on Antiplatelet Therapy
4. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
5. Studies Point to Benefits of Personalized Chemotherapy Dose Management in Colorectal Cancer
6. CureDMs Diabetes Therapy Achieves Major Development Milestone
7. Gene Therapy Improves Vision in Patients with Congenital Retinal Disease
8. Gene Therapy Provides Vision to People who Were Nearly Blind
9. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
10. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
11. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... and MENLO PARK, Calif. , ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... cancer therapies in new orphan drug indications, today ... and accredited investors for a registered direct placement ... and 3.35 million common stock purchase warrants for ...
(Date:7/27/2015)... --  DocResponse was ranked the most accurate ... peer-reviewed study , "Evaluation of symptom checkers for ... the July issue of The British Medical Journal ... researchers determined that performance of online symptom checkers ... first in standardized patient evaluations more often than ...
(Date:7/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/7lz2fk/intraoperative ) has ... by Type (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) , ... Forecast to 2019" report to their offering. ... value of $2.1 Billion by 2019 from $1.8 Billion ... forecast period. The intraoperative imaging market ...
Breaking Medicine Technology:DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 3Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 2Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 3Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market Forecasts & Trends 2015-2019 2
... 17, 2012  Boston Scientific Corporation (NYSE: BSX ... market launch of the Epic™ Vascular Self-Expanding Stent System.  ... in patients with iliac artery stenosis, a form of ... by insufficient blood flow.  "The Epic ...
... RARITAN, N.J., May 17, 2012 Janssen Pharmaceuticals, ... Phase 3 study suggesting NUCYNTA® ER (tapentadol) extended-release ... providing pain management among adults with chronic moderate ... of the study were presented at the 31st ...
Cached Medicine Technology:Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent 2Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent 3Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent 4Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent 5Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 2Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 3Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 4Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 5Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 6Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 7Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 8Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 9Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 10Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 11Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) 12
(Date:7/27/2015)... ... ... Eugene Batelli, D.P.M., F.A.C.F.A.S, just recently performed an innovative surgery to repair ... accomplishments include running in 27 triathlons and swimming the English Chanel. He came ... I did an ultrasound and found a partial chronic (old) tear. MRI ...
(Date:7/27/2015)... ... July 27, 2015 , ... David Gilmour has added additional ... for one additional night at each of his original four tour stops in the ... , David Gilmour’s 2016 North America tour dates: , Thursday, March 24, 2016 (3/24/16) ...
(Date:7/27/2015)... ... July 27, 2015 , ... With a new charity program in the ... its mission of reducing the number of deaths and injuries occurring from police pursuits, ... families. PursuitSAFETY works with the police to find better and safer ways to ...
(Date:7/27/2015)... ... , ... At Champagne Smiles, they know that tooth loss goes far beyond ... of stress, pain, discomfort and embarrassment, which is why they are proud to offer ... of implants with the cost savings of dentures for anyone on the market for ...
(Date:7/27/2015)... ... 27, 2015 , ... In a creative effort to provide clear information about ... The Ranch at Dove Tree in Lubbock has shared a new infographic to illustrate ... of recovery. Both the nationally recognized collegiate program and traditional adult program at The ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 2Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 3Health News:Cheap David Gilmour Tickets at Madison Square Garden (MSG), Air Canada Center, United Center and Hollywood Bowl: Additional Dates for David Gilmour Go On Sale Today 2Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 2Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 4Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 2Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 3
... the risk of death following a heart attack and reducing ... according to latest research. ,In a study of 15,570 ... outcome of death, heart attack, and stroke at seven and ... percent of patients in the placebo group to 9.6 percent ...
... with a long-acting beta2-agonist (formoterol) can actually provide significant ... high doses of inhaled steroid, say researchers according to ... of various combinations of medicine on asthma symptoms in ... were analyzed. The patients were divided into three treatment ...
... of alternative or complementary therapies have increased over the ... // at least one form of alternative medicine. Alternative ... hypnosis, acupuncture, chiropractic care, and high-dose vitamins. ... survey taken in 1997 to the National Health Interview ...
... A new study shows in as little as two days ... decrease, leading to diabetes and other related diseases.// ,Researchers ... the longer the rats stayed inactive. When the rats stopped ... three weeks, the amount of sugar taken into the muscle ...
... who carry a gene that produces a higher level ... risk for stroke.// ,Researchers reviewed medical literature on ... previous study results were observational in nature. A standard ... by looking at data on the link between homocysteine ...
... caused in Southeast Asia by the tsunami that hit on ... being carried out in the affected areas, on the opening ... the 32-member board is to discuss the broader topic of ... effective preparedness, response and recovery, in minimizing the impact on ...
Cached Medicine News:Health News:Who Board To Discuss Asian Tsunami Related Health Issues 2
... The REFLEXION 1st MPJ IMPLANT SYSTEM ... the primary reconstruction of the 1st metatarsal ... traumatic arthritis or revision of a previous ... achieve three goals: pain relief, superior function ...
... The hands play an important part in ... impairments and rheumatic changes can cause severe ... of the finger-joint prostheses was to produce ... the natural function as nearly possible.,The cementless ...
... The OSTEOMED 3.0/4.0mm CANNULATED SCREW SYSTEM ... Orthopedic Hand surgeon and Podiatrist, can be ... fusions. The system features two simplified ... Both screw sizes utilize one unique set ...
... the lower extremity for prepping before hip or ... procedures and particularly helpful for supporting the leg ... By holding the foot/ankle in an externally rotated ... which helps eliminate the need for manual support.,The ...
Medicine Products: